Preservation of growth hormone secretion in response to growth hormone- releasing peptide-2 during prednisone therapy

Metabolism: Clinical and Experimental

Volumn 48, Issue 5, 1999, Pages 585-589

  Meacham, L R ^a   Culler, F L ^b   Abdul Latif, H ^b   Sullivan, K M ^b   Bowers, C Y ^b  

^a Pediatric Endocrinology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PRALMORELIN; PREDNISONE; SOMATOSTATIN;

ADULT; ARTICLE; DRUG BINDING; DRUG MECHANISM; GROWTH HORMONE RELEASE; HORMONE PROTEIN COMPLEX; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; LONG TERM CARE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEROID THERAPY;

EID: 0032921424     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90055-0     Document Type: Article

References (13)

1. Baron J, Klein KO, Colli MJ, et al: Catch-up growth after glucocorticoid excess: A mechanism intrinsic to the growth plate. Endocrinology 135:1367-1371, 1994
2. Kaufmann S, Jones KL, Wehrenberg WB, et al: Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men. J Clin Endocrinol Metab 67:1258-1261, 1988
3. Tannebaum GS, Ling N: The interrelationship of growth hormone releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115:152-157, 1984
4. Penalva A, Carballo A, Pombo M, et al: Effect of growth hormone (GH)-releasing hormone (GHRH), atropine pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J Clin Endocrinol Metab 76:168-171, 1993
5. Cordido F, Penalva A, Dieguez C, et al: Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 76:819-823, 1993
6. Popovic V, Damjanovic S, Micic D, et al: Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947, 1995
7. Robinson BM, Friberg RD, Bowers CY, et al: Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone. J Clin Endocrinol Metab 75:1121-1124, 1992
8. Loche S, Cambiaso P, Carta D, et al: The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitarism subjects. J Clin Endocrinol Metab 80:674-678, 1995
9. Arvat E, Gianotti L, Grottoli S, et al: Arginine and growth hormone-releasing hormone restore the blunted growth hormone releasing activity of Hexarelin in elderly subjects. J Clin Endocrinol Metab 79:1440-1443, 1994
10. Ghigo E, Arvat E, Muccioli G, et al: Growth hormone-releasing peptides. Eur J Endocrinol 136:445-460, 1997
11. Gertz BJ, Sciberras DG, Yogendran L, et al: L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 79:d745-d749, 1994
12. Alba-Roth J, Muller OA, Schopohl J, et al: Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189, 1988
13. Pihoker C, Middleton R, Reynolds GA, et al: Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. J Clin Endocrinol Metab 80:2987-2992, 1995